Xenetic Biosciences, Inc.
XBIO
$2.30
-$0.08-3.36%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -3.45% | 0.49% | 11.58% | -15.68% | 37.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.45% | 0.49% | 11.58% | -15.68% | 37.99% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -3.45% | 0.49% | 11.58% | -15.68% | 37.99% |
| SG&A Expenses | -25.87% | 1.15% | 19.45% | -9.81% | 11.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.32% | -36.65% | 11.61% | 16.98% | -5.98% |
| Operating Income | 12.47% | 56.44% | -11.62% | -38.59% | 19.68% |
| Income Before Tax | 9.99% | 58.63% | -21.22% | -39.52% | 20.98% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 9.99% | 58.63% | -21.22% | -39.52% | 20.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.99% | 58.63% | -21.22% | -39.52% | 20.98% |
| EBIT | 12.47% | 56.44% | -11.62% | -38.59% | 19.68% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 10.19% | 58.88% | -19.95% | -37.34% | 22.63% |
| Normalized Basic EPS | 10.19% | 58.89% | -19.96% | -37.34% | 22.63% |
| EPS Diluted | 10.19% | 58.88% | -20.29% | -37.34% | 22.90% |
| Normalized Diluted EPS | 10.19% | 58.89% | -19.96% | -37.34% | 22.63% |
| Average Basic Shares Outstanding | 0.22% | 0.59% | 1.06% | 1.58% | 2.14% |
| Average Diluted Shares Outstanding | 0.22% | 0.59% | 1.06% | 1.58% | 2.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
